BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 27784782)

  • 1. Glucocorticoid Receptor β Induces Hepatic Steatosis by Augmenting Inflammation and Inhibition of the Peroxisome Proliferator-activated Receptor (PPAR) α.
    Marino JS; Stechschulte LA; Stec DE; Nestor-Kalinoski A; Coleman S; Hinds TD
    J Biol Chem; 2016 Dec; 291(50):25776-25788. PubMed ID: 27784782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
    J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21.
    Li Y; Wong K; Giles A; Jiang J; Lee JW; Adams AC; Kharitonenkov A; Yang Q; Gao B; Guarente L; Zang M
    Gastroenterology; 2014 Feb; 146(2):539-49.e7. PubMed ID: 24184811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Protective effect of glycogen synthase kinase 3β inhibition via peroxisome proliferator-activated receptor alpha activation in mice with acute liver failure].
    Shi HB; Shi HL; Zhang XY; Chen DX; Duan ZP; Ren F
    Zhonghua Gan Zang Bing Za Zhi; 2017 Mar; 25(3):211-216. PubMed ID: 28482409
    [No Abstract]   [Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor α activation induces hepatic steatosis, suggesting an adverse effect.
    Yan F; Wang Q; Xu C; Cao M; Zhou X; Wang T; Yu C; Jing F; Chen W; Gao L; Zhao J
    PLoS One; 2014; 9(6):e99245. PubMed ID: 24926685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
    Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
    Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet.
    Tanaka N; Takahashi S; Zhang Y; Krausz KW; Smith PB; Patterson AD; Gonzalez FJ
    Biochim Biophys Acta; 2015 Jul; 1852(7):1242-52. PubMed ID: 25736301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-3 long-chain PUFA supplementation prevents high fat diet induced mouse liver steatosis and inflammation in relation to PPAR-α upregulation and NF-κB DNA binding abrogation.
    Tapia G; Valenzuela R; Espinosa A; Romanque P; Dossi C; Gonzalez-Mañán D; Videla LA; D'Espessailles A
    Mol Nutr Food Res; 2014 Jun; 58(6):1333-41. PubMed ID: 24436018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of the human glucocorticoid receptor alpha and beta isoforms inhibits AP-1 and NF-kappaB activities hormone independently.
    Gougat C; Jaffuel D; Gagliardo R; Henriquet C; Bousquet J; Demoly P; Mathieu M
    J Mol Med (Berl); 2002 May; 80(5):309-18. PubMed ID: 12021843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARalpha blocks glucocorticoid receptor alpha-mediated transactivation but cooperates with the activated glucocorticoid receptor alpha for transrepression on NF-kappaB.
    Bougarne N; Paumelle R; Caron S; Hennuyer N; Mansouri R; Gervois P; Staels B; Haegeman G; De Bosscher K
    Proc Natl Acad Sci U S A; 2009 May; 106(18):7397-402. PubMed ID: 19376972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility to diet-induced hepatic steatosis and glucocorticoid resistance in FK506-binding protein 52-deficient mice.
    Warrier M; Hinds TD; Ledford KJ; Cash HA; Patel PR; Bowman TA; Stechschulte LA; Yong W; Shou W; Najjar SM; Sanchez ER
    Endocrinology; 2010 Jul; 151(7):3225-36. PubMed ID: 20427484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium Butyrate Ameliorates High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease through Peroxisome Proliferator-Activated Receptor α-Mediated Activation of β Oxidation and Suppression of Inflammation.
    Sun B; Jia Y; Hong J; Sun Q; Gao S; Hu Y; Zhao N; Zhao R
    J Agric Food Chem; 2018 Jul; 66(29):7633-7642. PubMed ID: 29961332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty Acid Desaturase 1 Influences Hepatic Lipid Homeostasis by Modulating the PPARα-FGF21 Axis.
    Athinarayanan S; Fan YY; Wang X; Callaway E; Cai D; Chalasani N; Chapkin RS; Liu W
    Hepatol Commun; 2021 Mar; 5(3):461-477. PubMed ID: 33681679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic Small Ubiquitin-Related Modifier (SUMO)-Specific Protease 2 Controls Systemic Metabolism Through SUMOylation-Dependent Regulation of Liver-Adipose Tissue Crosstalk.
    Liu Y; Dou X; Zhou WY; Ding M; Liu L; Du RQ; Guo L; Qian SW; Tang Y; Yang QQ; Pan DN; Li XY; Lu Y; Cheng JK; Tang QQ
    Hepatology; 2021 Oct; 74(4):1864-1883. PubMed ID: 33934381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant miR199a-5p/caveolin1/PPARα axis in hepatic steatosis.
    Li B; Zhang Z; Zhang H; Quan K; Lu Y; Cai D; Ning G
    J Mol Endocrinol; 2014 Dec; 53(3):393-403. PubMed ID: 25312970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a Toll-like receptor 4/NF-κB signaling pathway.
    Wu HM; Ni XX; Xu QY; Wang Q; Li XY; Hua J
    J Gastroenterol Hepatol; 2020 Nov; 35(11):1998-2008. PubMed ID: 32128893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Betaine prevented fructose-induced NAFLD by regulating LXRα/PPARα pathway and alleviating ER stress in rats.
    Ge CX; Yu R; Xu MX; Li PQ; Fan CY; Li JM; Kong LD
    Eur J Pharmacol; 2016 Jan; 770():154-64. PubMed ID: 26593707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.